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1. Introduction 
Spinal anaesthesia is com-
monly used for elective caesarean 
section, and has a lot of advan-
tages. It is easier and quicker 
than epidural anaesthesia and it 
exposes the fetus to fewer drugs 
than general anaesthesia. But the 
best benefit of spinal anaesthesia 
for elective caesarean section is 
the mother̀ s ability to be con-
scious when her baby is delivered. 
However, spinal anaesthe-
sia has some disadvantages and 
complications in intra- and post-
operative period. Maternal hy-
potension is the most frequent 
complication of spinal anaesthe-
sia for caesarean section, thus 
can affect 90 % of women and 
can be associated with nausea 
and vomiting, fetal acidosis and 
in severe cases fetal bradycardia. 
It сan be the source of serious 
risks to the mother (pulmonary 
aspiration, unconsciousness) and 
baby (hypoxia, acidosis, neuro-
logical injury, etc) [1, 2].
Maternal hypotension, nau-
sea and vomiting are significant-
ly more frequent during spinal 
anaesthesia for caesarean section 
than during non-obstetric sur-
gery. The aetiology of this is 
multifactorial (the sympathetic 
vasomotor block caused by spinal 
anaesthesia, inferior vena cava 
compression, acute hypotension 
reduces cerebral perfusion, in-
duces transient brainstem isch-
aemia and activates the vomiting 
centre [3], secondary low system-
ic vascular resistance and artery 
vasodilation due to progesterone 
action, hormonally caused hyper-
sensitivity of nerve fibres of local 
anaesthetics and opioids, etc).
Intrathecal opioids are fre-
quently administered to patients 
undergoing elective caesarean 
section under spinal anaesthe-
sia for postoperative analgesia. 
The incidence of postoperative 
nausea and vomiting (PONV) in 
patients who have received an intrathecal opiate is 60–80 % [4]. 
The reported incidence of intrathecal opioid-induced pruritus is 
20–90 % [5]. Although the prophylactic and therapeutic effects 
of several antiemetic and antipruritic drugs have been exten-
sively studied, a decrease in the incidence of PONV and pruritus 
after intrathecal opioids remains a major therapeutic challenge.
A lot of systematic reviews and network meta‐analysis allow 
us to compare methods of prevention maternal hypotension, 
nausea and vomiting, pruritus in women receiving spinal anaes-
thesia for caesarean section [1–3, 6].
Vasopressors should be given 
to healthy women to prevent hy-
potension during caesarean sec-
tion with spinal anaesthesia (Gr. 
high to moderate) [2, 7]. 
The aim should be to main-
tain systolic arterial pressure 
(SAP) at ≥90 % of an accurate 
baseline obtained before spinal 
anaesthesia and avoid a decrease 
to <80 % baseline. It is recom-
mended variable rate prophy-
lactic infusion of phenylephrine 
using a syringe pump (started 
at 25–50 µg.min-1 immediately 
after the intrathecal local anaes-
thetic injection, and titrated to 
blood pressure and pulse rate) 
[3, 7]. The SAP is a less import-
ant variable than mean arterial 
pressure (MAP) as a determinant 
of organ perfusion; however, be-
cause methods used to measure 
blood pressure in routine clinical 
practice did not include the mean 
until recent decades.
But while interventions such 
as crystalloids, colloids, ephed-
rine, phenylephrine, ondanse-
tron, left lateral position, or low-
er leg compression can reduce 
the incidence of hypotension, 
none have been shown to elim-
inate the need to treat maternal 
hypotension in some women. 
That is why it is important to find 
new, simple and safe methods of 
improvement spinal anaesthesia 
for elective caesarean section.
Dexamethasone is a potent 
anti-inflammatory agent which 
has been investigated in the last 
decade for its role as an adjuvant 
to local anaesthetics in neurax-
ial as well as peripheral nerve 
blocks.
The mechanisms by which 
steroids potentiate the analgesic 
effects seem to be different from 
its intrinsic anti-inflammatory 
mechanism [4]. There is also 
evidence to show that the lo-
cal action on nerve fibres and 
systemic effects, both potentiate 
dexamethasone’s analgesic properties [8, 9]. Both perineural 
and intravenous dexamethasone may prolong duration of 
sensory block and are effective in reducing postoperative 
pain intensity and opioid consumption [5]. Local wound in-
filtration of dexamethasone is more effective than systemic 
administration to decrease postoperative pain with weaker 
antiemetic effect [10]. But combination of dexamethasone 
and ondansetron administered prophylactically significantly 
reduced the incidence of PONV in pregnant women on in-
trathecal morphine for caesarean section. Addition of dexa-
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period (24 h). The complications that required medicines cor-
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and χ2=0.479, p<0.05) in intra- and postoperative period after 
the spinal anaesthesia in elective caesarean section. Intrathecal 
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shivering (Pearson's χ2=0.316, p<0.05) in intra- and postoper-
ative period, and significantly didn`t impact on vomiting and 
bradycardia.
Conclusions: the addition of 4 mg intrathecal dexamethasone 
as an adjuvant for spinal anaesthesia can significantly decrease 
frequency and manifestations of arterial hypotonia and nausea, 
reduce shivering during perioperative period. The addition of 
8 mg intravenous dexamethasone has not the same quality. 
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methasone to bupivacaine in spinal anaesthesia significantly 
improved the duration of sensory block/surgical analgesia as 
well as post-operative analgesia/pain free period without any 
complications [11].
The aim of this study was to evaluate the efficacy of intra-
thecal or intravenous dexamethasone to prevent some early 
complications of spinal anaesthesia such as arterial hypotonia, 
nausea, vomiting, bradycardia, shivering etc. 
2. Materials and methods
During 2019–2020 a randomized, prospective, double-blind-
ed, placebo-controlled clinical trial were performed in Kyiv City 
Center of Reproductive and Perinatal Medicine. Study design 
was approved by Ethics committee of Shupik National medical 
Academy of Postgraduate education (No. 1, 04.02.2019). Ac-
cording to Helsinki declaration, all the patients were informed 
regarding aim and methods of the current study and had pro-
vided the written informed consent. 
A total of 154 healthy, not obese women, ASA I–II, 18–36 
years old, 36–40 weeks of gestation undergoing elective caesar-
ean section under spinal anaesthesia were randomly divided 
into three equal groups. All patients were randomized by age, 
weight and growth rates, BMI, gestational period, assessment of 
somatic status, indications for surgery, duration of surgery, and 
postoperative period in ICU.
The women of each group received intrathecal hyperbaric 
bupivacaine 0.5 % 10 mg.
Group B (n=51) additionally received intrathecal 1 ml of 
normal saline like placebo.
Group BD (n=52) additionally received 4mg (1 ml) intrathe-
cal dexamethasone.
Group D (n=51) received 8 mg intravenous dexamethasone 
directly after spinal puncture. 
All data of patient̀ s monitoring were recorded before spinal 
puncture at 1, 5, 10, 20, 30 minutes of operation, at the end of 
operation, every hour during post-operative period (24 h). The 
patients were evaluated for blood pressure (including mean arte-
rial pressure (MAP)), heart rate, nausea, vomiting, shivering or 
other complications during intra- or postoperative period. The 
complications that required medicines correction were recorded 
and cured.
All obtained data from the study were processed using 
SPSS software by methods of variational statistics. As for 
statistical data analysis, continuous variables were present-
ed as mean ± standard deviation when they 
were normally distributed, or median and inter-
quartile range if otherwise. Categorical variables 
were presented as frequencies and percentages. 
Mann-Whitney criteria were used for intergroup 
differences and quantitative values. The qualita-
tive variables were expressed as percentages and 
were analyzed by the χ2 test and exact Fisher test. 
All differences were considered statistically sig-
nificant with p≤0.05.
3. Results
Mean arterial pressure (MAP) more than SAP 
is a determinant of organ perfusion. Continuous 
variables of MAP are presented as median and 
interquartile range in Table 1.
Pairwise group comparisons of mean arteri-
al pressure (MAP) were performed statistically 
significant differences in Group BD vs Group B 
(p≤0.012 and p≤0.023) at 5 min and 10 min after 
spinal puncture. In addition, no significant differences were 
found in the comparative characteristics of groups at 0 min, 
1 min, 30 min after spinal puncture. 
The same trends of arterial pressure were performed 
in Fig. 1. There were presented statistically significant differ-
ences in Group BD vs Group B (p≤0.014 and p≤0.026) at 5 min 
and 10 min after spinal puncture. Only in Group BD arterial 
pressure was holding on accurate baseline obtained before spi-
nal anaesthesia and avoid a decrease to < 80 % baseline.
Table 1






BD 85 95 98
B 87 96 99
D 85 94 97
1 min
BD 88 97 103
B 94 95 102
D 90 98 100
5 min
BD 69 70 75
B 54 57 60
D 63 65 69
10 min
BD 74 77 80
B 65 66 69
D 71 74 80
20 min
BD 83 85 87
B 88 81 83
D 82 83 85
Arterial hypotension, nausea, vomiting, bradycardia, shiv-
ering are the most frequent complications of spinal anaesthesia 


































Group D                              C  A – Trends of blood pressure in       
Gr.B- placebo 
B – Trends of blood pressure in 
Gr.BD- intrathecal dexamethasone 
C – Trends of blood pressure in 
Gr.D- intravenous dexamethasone 
Black line – Baseline=100 mmHg 
Fig. 1. The review of blood pressure trends in the research groups
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4. Discussion
The addition of intrathecal dexamethasone in Group BD vs 
Group B significantly decreased frequency and manifestations 
of arterial hypotension and nausea (Pearson’s χ2=0.486 and 
χ2=0.479, p=0.002 in both cases) in intra- and postoperative 
period after the spinal anaesthesia in elective caesarean section.
After intrathecal dexamethasone addition mean arterial 
pressure (MAP) will be significantly higher (p≤0.012 and 
p≤0.023) at 5 min and 10 min after spinal puncture.
The addition of intrathecal dexamethasone in Group BD vs 
Group B significantly reduced shivering (Pearson’s χ2=0.316, 
p<0.05) in intra- and postoperative period, and significantly 
didǹ t affected on vomiting and bradycardia.
Intravenous and intrathecal dexamethasone has the same 
impact factor for nausea (no significant difference, p=0.539) 
during spinal anaesthesia for elective caesarean section, but 
intrathecal dexamethasone is better for prevention arterial hy-
potension (p=0.002).
Only whole complex of intervention, including different im-
pact factors, can prevent or reduce some early complications of 
spinal anaesthesia, such as arterial hypotonia, nausea, vomiting, 
bradycardia, shivering etc.
A lot of systematic reviews and network meta‐analysis 
allow us to compare methods of prevention maternal hypo-
tension, nausea and vomiting, pruritus in women receiving 
spinal anaesthesia for caesarean section [1–3]. There are a lot 
of information about intravenous dexamethasone for this pur-
pose [4, 12]. But there are absent large, high-quality evidence 
studies about intrathecal dexamethasone for prevention early 
complications of spinal anaesthesia for elective caesarean 
section, such as arterial hypotonia, nausea, vomiting, brady-
cardia, shivering etc.
Тhe advantage of the studied method of spinal anaesthesia 
for elective caesarean section is availability to reduce the inci-
dence and manifestations of early complications of spinal anaes-
thesia by using one single-shot injection of complex medicines 
(local anaesthetic bupivacaine 0.5 % 10 mg and additionally 
4 mg intrathecal dexamethasone as adjuvant).
The disadvantages of this method are unclear mechanism 
of the actions for intrathecal dexamethasone, insufficient data 
about optimal dose and long-term effects of intrathecal dexa-
methasone, the need for legal support and implementation 
of new spinal anesthesia protocols and drug instructions for 
using intrathecal dexamethasone, introduction of new preser-
vative-free forms of drugs, etc. Implementation of this method 
in patients with preeclampsia has certain limitations (due to the 
blood pressure increasing effect).
That is why there is still a need for large randomised multi-
central clinical trials to research intrathecal dexamethasone as 
an adjuvant for spinal anaesthesia for elective caesarean section.
As a result, it will be able to obtain and implement a new 
methodology for spinal anaesthesia of elective caesarean sec-
tion, which will improve the patient’s well-being during cesar-
ean section and in the postoperative period, will promote early 
activation and socialization of the patient.
Study limitations. The small number of patients in the sam-
ple groups and the limited time period were certain limitations 
for this study.
Prospects for further research. The addition of intrathecal 
dexamethasone as an adjuvant for spinal anaesthesia of elective 
caesarean section improve the patient’s well-being during cesar-
ean section and in the postoperative period and facilitate early 
activation and socialization of the patient.
There is still a need for large randomised multicentral 
clinical trials to research intrathecal dexamethasone as an ad-
juvant for spinal anaesthesia for elective caesarean section (for 
clarification and study of new properties, mechanism of action, 
optimal dose, long-term effects of this medicine and method of 
anaesthesia).
5. Conclusions
Maternal hypotension is the most frequent complication of 
spinal anaesthesia for caesarean section and can be associated 
with nausea and vomiting. But while interventions such as 
crystalloids, colloids, ephedrine, phenylephrine, ondansetron, 
left lateral position, or lower leg compression can reduce the in-
cidence of hypotension, none have been shown to eliminate the 
need to treat maternal hypotension in some women.
The addition of 4 mg intrathecal dexamethasone as an adju-
vant for spinal anaesthesia can significantly decrease frequency 
and manifestations of arterial hypotonia and nausea, reduce 
shivering during perioperative period. The addition of 8 mg 
intravenous dexamethasone has not the same quality.
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Table 2
The review of complications in the research groups
Complications*
Group






n=51 В-BD B-D В-BD B-D В-BD B-D В-BD
Arterial hypoten-sion 33 15 27 0.004 0.236 p≤0.05 p≥0.05 0.479 0.169 strong
Nausea 26 9 24 0.003 0.843 p≤0.05 p≥0.05 0.474 0.056 strong
Vomi-ting 5 1 2 0.269 0.274 p≥0.05 p≥0.05 0.166 0.158 weak
Brady-cardia 15 6 11 0.029 0.376 p≤0.05 p≥0.05 0.306 0.127 middle
Shive-ring 23 12 19 0.023 0.546 p≤0.05 p≥0.05 0.321 0.124 middle
Note: complication that required medicines correction
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